(Q38305959)

English

Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation

scientific article published on December 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation (English)

1 reference

Europe PubMed Central

2 September 2017

0 references

lung transplant

1 reference

based on heuristic

inferred from title

bronchoalveolar lavage

1 reference

based on heuristic

inferred from title

author name string

Scholma J

1

1 reference

Europe PubMed Central

2 September 2017

Slebos DJ

2

1 reference

Europe PubMed Central

2 September 2017

Boezen HM

3

1 reference

Europe PubMed Central

2 September 2017

van den Berg JW

4

1 reference

Europe PubMed Central

2 September 2017

van der Bij W

5

1 reference

Europe PubMed Central

2 September 2017

de Boer WJ

6

1 reference

Europe PubMed Central

2 September 2017

Koëter GH

7

1 reference

Europe PubMed Central

2 September 2017

Timens W

8

1 reference

Europe PubMed Central

2 September 2017

Kauffman HF

9

1 reference

Europe PubMed Central

2 September 2017

Postma DS

10

1 reference

Europe PubMed Central

2 September 2017

language of work or name

0 references

publication date

1 December 2000

1 reference

Europe PubMed Central

2 September 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

2 September 2017

162

1 reference

Europe PubMed Central

2 September 2017

6

1 reference

Europe PubMed Central

2 September 2017

2221-2225

1 reference

Europe PubMed Central

2 September 2017

The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

Altered nonspecific lymphocyte cytotoxicity in bronchoalveolar lavage of lung transplant recipients: can it be useful in monitoring rejection or infection?

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

Bronchoalveolar lavage in lung transplantation. State of the art.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

The evolution of techniques and indications for lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

Anatomical distribution of bronchoalveolar lavage fluid as assessed by digital subtraction radiography.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

Bronchiolitis obliterans: pathogenesis, prevention, and management

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.6.9911104

21 January 2018

Identifiers

10.1164/AJRCCM.162.6.9911104

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38305959&oldid=1909630898"